Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...
A Minnesota-based company is recalling more than 348,000 defibrillators over concerns that they may not work. Medtronic, which has its executive headquarters based in Minneapolis, initiated the recall ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results